A takeover bid, a next-generation sweetener breakthrough and renewed inflation concerns may seem like separate occurrences, but together they reveal how quickly the industry is reshaping itself.
Ingredion’s takeover play
Ingredion’s proposed $3.7 billion acquisition of Tate & Lyle has potential to create a $10 billion global ingredient company.
Both companies have been repositioning themselves toward higher-value solutions like texture platforms, ingredient fortification and sugar reduction – areas that are increasingly critical as manufacturers balance cost, health and functionality.
For Ingredion, the acquisition signals a broader interest in texture and healthful solutions that offer higher margins across savory, dairy, bakery, snacks and beverage.
If approved, Ingredion will add Tate & Lyle’s sugar reduction portfolio to its existing sweeteners, starches, ingredients and biomaterials .
The move also reflects a broader industry shift: Companies are not just consolidating, they are investing in their growth and market presence.
Kraft Heinz’s recent decision not to split the company into two entities and rather focus on hiring, marketing and R&D to reignite growth aligns with how large CPGs are carefully positioning themselves in an increasingly cost-sensitive landscape without relying on price increases.
Read the full story here: Ingredion’s Tate & Lyle buy would create a $10B global ingredient powerhouse
Sweet disruption and the ‘better-for-you’ reality check
Innovation in ingredients continues to accelerate, particularly in sugar reduction.
Biotech company Amai Proteins’ recent Singapore regulatory approval for its precision-fermentation sweet protein sweelin marks a notable milestone to begin commercialization in APAC, not just for the company but for the broader category of next-generation sweeteners.
The company’s Singapore approval follows after receiving its Generally Recognized as Safe (GRAS) status in the US earlier this year. Amai is awaiting regulatory approval in Israel, with plans to continue expanding into Canada, Latin America and the broader APAC region.
Sweet proteins are positioned as a high-intensity alternative to standard sweeteners and sugar. Other companies, like Oobli and MycoTechnology, are gaining momentum with their own sweet proteins, which can significantly reduce sugar content while maintaining taste. The emerging sweet protein sector aligns with what manufacturers need as they reformulate products under both health and cost pressure.
Amai’s US and Singapore presence also reflects the growth of “better-for-you” beyond niche to one of the most commercially important areas of the store.
Retailers like Target are seeing 50% sales growth protein and functional beverages in the first quarter.
The rise of health-focused private label also is reshaping consumer access to healthier items, as retailers double down on store brands that deliver better-for-you positioning alongside value.
But shoppers also increasingly want proof of better-for-you benefits, whether that’s functionality, credible claims or visible value.
Read the full story here: Sweet proteins gain global momentum with latest regulatory win
Inflation pressure shaping consumer and industry decisions
Cost pressures underlie shifts in investment strategies and demand for healthier options .
Concerns that food inflation could rise again in 2026 continue to shape both consumer behavior and companies’ strategy. Costs tied to energy, labor and supply chains continue to create volatility, while category-level price swings complicate planning.
For consumers, food inflation means ongoing price sensitivity. For companies, it reinforces the need to balance affordability with innovation, while still investing in growth.
Read the full story here: Iran war fallout hits grocery aisles as food inflation surges and shoppers pull back
